The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Tags · Evidence

observational data

Cohort, registry and claims data, with the confounding that comes with it.

67 topics 21 solved Group: Evidence

Related in this group: STEP programme · SURMOUNT programme · SURPASS programme · SELECT trial · FLOW trial · SOUL trial · TRIUMPH programme · PIONEER programme · SUSTAIN programme · LEADER trial · randomised trial · meta-analysis

67 topics · page 2 of 3

TopicParticipantsRepliesViewsActivity
Reverse causation in a cohort study of weight and outcome
On the subject in the title: Reverse causation in a cohort study of weight and outcome Working notes rather than a conclusion. Posting a small dataset on reverse causation. It is mine, it is uncontrolled, and…
LVDRIEDDN+10 14 11k 7mo
Selection into a registry and what it does to the estimate
Selection into a registry and what it does to the estimate — setting out what I have, and where I think it stops being reliable. Working notes on selection rather than a conclusion. I would rather post the…
SSLMAA 2 55k 7mo
Critiquing an observational claim about a class effect — one year on
Critiquing an observational claim about a class effect — one year on — setting out what I have, and where I think it stops being reliable. I was wrong about Critiquing an observational claim in a thread last…
FELDKRAWDO+5 9 3.2k 8mo
Revisiting: Sample size in a voluntary survey: the selection problem
Revisiting: Sample size in a voluntary survey: the selection problem — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin Sample size down and I want to…
RAZAR 2 56k 9mo
Aggregated purity results across four services, with caveats
Posting this under the heading it deserves: Aggregated purity results across four services, with caveats Everything below is what sits behind that. Aggregated purity results across four, from the point of…
CPEKLMHK 3 24k 9mo
Coming back to: A community side-effect dataset, with its response rate and biases
On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Reading back through what has been written here about community…
AATSCNPMA+27 31 46k 9mo
Reading a rodent study on a secretagogue without over-extrapolating
Posting this under the heading it deserves: Reading a rodent study on a secretagogue without over-extrapolating Everything below is what sits behind that. Reading a rodent study, and specifically the version…
EKLLTVOF+50 54 32k 10mo
BPC-157: what the rodent literature actually shows, and what it does not
BPC-157: what the rodent literature actually shows, and what it does not — setting out what I have, and where I think it stops being reliable. I would like to know what people here actually do about BPC-157,…
PILSTMIAK+44 48 3k 10mo
Analytical identity of BPC-157: a 15-mer with a simple mass
Analytical identity of BPC-157: a 15-mer with a simple mass Writing it up because I had to work it out twice and would rather nobody else did. Something about analytical identity of BPC-157 does not reconcile…
MRFNLVWPII+3 7 5.2k 10mo
Reverse causation in a cohort study of weight and outcome — a second dataset
Reverse causation in a cohort study of weight and outcome — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Reverse causation. It…
MRAKANKBVK+112 131 1.5k 10mo
Aggregated purity results across four services, with caveats — a second dataset
Aggregated purity results across four services, with caveats — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Aggregated purity results…
CWFNHLTHRE+127 151 42k 10mo
Second pass at: Why this subcategory is stricter about sourcing than most
Second pass at: Why this subcategory is stricter about sourcing than most — setting out what I have, and where I think it stops being reliable. A comparison question rather than a question about one compound.…
AWGHTVCDAS+120 129 61k 11mo
Confounding by indication, explained with a concrete example
On the subject in the title: Confounding by indication, explained with a concrete example Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-2 ( N Engl J Med ,…
TVARBDSBCD+21 25 21k 11mo
Immortal time bias in a claims-database study
Immortal time bias in a claims-database study — setting out what I have, and where I think it stops being reliable. Asking about immortal time bias directly, because I have read four threads on it and each…
MACDSOIDNN+29 34 28k 11mo
TB-500 and thymosin beta-4: the fragment versus the protein
TB-500 and thymosin beta-4: the fragment versus the protein Writing it up because I had to work it out twice and would rather nobody else did. TB-500 and thymosin beta-4: what I expected, what I found, and…
COGDJLDVS+107 118 22k 11mo
BPC-157: what the rodent literature actually shows, and what it does not — a second dataset
On the subject in the title: BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Working notes rather than a conclusion. The question about BPC-157 that I actually want…
WNCDSOOSB+77 84 54k 11mo
IGF-1 as a surrogate endpoint and its limitations — the long version
On the subject in the title: IGF-1 as a surrogate endpoint and its limitations — the long version Working notes rather than a conclusion. A narrow question about IGF-1, deliberately narrow, because the broad…
NOMGCRKBGP+14 18 53k 12mo
About the Datasets category
Community-collected datasets, their collection methods, and their limitations. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
BNOFSVPSAA+6 11 42k 12mo
About the Repair & healing peptides category
BPC-157, TB-500 and similar. Mostly preclinical evidence; this subcategory is strict about not overstating it. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
SLHSENALEF 4 19k 13mo
Whether an aggregate is worth publishing at all: a disputed topic
On the subject in the title: Whether an aggregate is worth publishing at all: a disputed topic Working notes rather than a conclusion. An honest uncertainty about whether an aggregate rather than a disguised…
PEGLIGHNMD+20 24 18k 13mo
Why plausible mechanism is not evidence of effect
Asking directly, because I could not find a straight answer: Why plausible mechanism is not evidence of effect What changes if the standard account of plausible mechanism is wrong? I ask because I have been…
FYGFSPCNAK+14 18 57k 13mo
A claim built entirely on a subgroup analysis
A claim built entirely on a subgroup analysis Writing it up because I had to work it out twice and would rather nobody else did. I would like to disagree carefully with the settled view on claim built, and I…
ASKHMIASNP+71 80 1.1k 14mo
A well-designed study with a badly written abstract
Posting this under the heading it deserves: A well-designed study with a badly written abstract Everything below is what sits behind that. Reading back through what has been written here about well-designed…
RCMICBMRPN+117 128 7.2k 14mo
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence
Posting this under the heading it deserves: Tesamorelin has an approved indication — what that changes about the evidence Everything below is what sits behind that. What changes if the standard account of…
RLHFTDIBBW+63 68 18k 14mo
Critiquing an observational claim about a class effect
Posting this under the heading it deserves: Critiquing an observational claim about a class effect Everything below is what sits behind that. I was wrong about critiquing an observational claim in a thread…
VRRIJV 2 6.9k 14mo
Ipamorelin selectivity claims and where they came from — a second dataset
Posting this under the heading it deserves: Ipamorelin selectivity claims and where they came from — a second dataset Everything below is what sits behind that. Posting a small dataset on Ipamorelin…
TIDCM 2 27k 14mo
Coming back to: A critique that turned out to be unfair, retracted by its author
A critique that turned out to be unfair, retracted by its author — setting out what I have, and where I think it stops being reliable. Reading back through what has been written here about critique, three…
IAQLJB 2 1.3k 14mo
Criticising the method without criticising the authors
Criticising the method without criticising the authors Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about criticising the method without criticising in a…
KBZOKOJMTV+55 61 60k 15mo
Revisiting: Oral versus injected administration claims for BPC-157
On the subject in the title: Revisiting: Oral versus injected administration claims for BPC-157 Working notes rather than a conclusion. A follow-up question about Oral versus injected administration claims…
IGAAILRILD+23 27 7.7k 15mo
Sample size in a voluntary survey: the selection problem
Posting this under the heading it deserves: Sample size in a voluntary survey: the selection problem Everything below is what sits behind that. Sample size: setting out the arithmetic in full, because I have…
BVLDNLAIEK+1 5 12k 15mo